67457-227 : Cosyntropin .25 mg/ml Intramuscular; Intravenous Injection, Powder, for Solution


NDC67457-227
Labeler: Mylan Institutional LLC
Product Type: Human Prescription Drug
Drug Name:  Cosyntropin
Dosage Form: Intramuscular; Intravenous Injection, Powder, for Solution
Application #: ANDA090574
Rev. Date: 


NDC Package Codes:

  • 67457-227-02: 10 VIAL IN 1 CARTON (67457‑227‑02) > 1 ML IN 1 VIAL (67457‑227‑00)

Active Ingredients:

  • Cosyntropin

Dosage Strength:

  • .25 mg/mL

Pharmaceutical Classes:

  • Adrenocorticotropic Hormone [CS]
  • Adrenocorticotropic Hormone [EPC]

Related Products:

Based on records with the same trade name.
  • 67457-257 Cosyntropin .25 mg/ml Intramuscular; Intravenous Injection, Powder, for Solution by Mylan Institutional LLC
  • 0781-3052 Cosyntropin .25 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-3440 Cosyntropin .25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
  • 10139-905 Cosyntropin .25 mg/ml Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Generamedix
  • 51662-1567 Cosyntropin .25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hf Acquisition Co LLC, Dba Healthfirst

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 67457-227 QR Code

< Prev: 67457-226Next: 67457-228 >

Related Discussions:

Cosyntropin (Sandoz vs Amphastar)
I can see that the Amphastar product is the one mostly usded. Can anyone tell me what is the difference between the Sand...
Cosyntropin Side Effects
I have been invited to participate in a study using this drug. I was unable to access information about this drug on the...




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.